» Articles » PMID: 37965897

Organ-On-A-Chip: An Emerging Research Platform

Overview
Journal Organogenesis
Date 2023 Nov 15
PMID 37965897
Authors
Affiliations
Soon will be listed here.
Abstract

In drug development, conventional preclinical and clinical testing stages rely on cell cultures and animal experiments, but these methods may fall short of fully representing human biology. To overcome this limitation, the emergence of organ-on-a-chip (OOC) technology has sparked interest as a transformative approach in drug testing research. By closely replicating human organ responses to external signals, OOC devices hold immense potential in revolutionizing drug efficacy and safety predictions. This review focuses on the advancements, applications, and prospects of OOC devices in drug testing. Based on the latest advances in the field of OOC systems and their clinical applications, this review reflects the effectiveness of OOC devices in replacing human volunteers in certain clinical studies. This review underscores the critical role of OOC technology in transforming drug testing methodologies.

Citing Articles

Identifying Specificity Protein 2 as a key marker for diabetic encephalopathy in the context of predictive, preventive, and personalized medicine.

Tao G, Wang X, Wang J, Ye Y, Zhang M, Lang Y EPMA J. 2025; 16(1):67-93.

PMID: 39991102 PMC: 11842694. DOI: 10.1007/s13167-024-00394-0.


Exploring oncology treatment strategies with tyrosine kinase inhibitors through advanced 3D models (Review).

Isinelli G, Failla S, Plebani R, Prete A Med Int (Lond). 2025; 5(2):13.

PMID: 39790707 PMC: 11707505. DOI: 10.3892/mi.2024.212.


Modeling intratumor heterogeneity in breast cancer.

McDonough E, Barroso M, Ginty F, Corr D Biofabrication. 2024; 17(1.

PMID: 39642392 PMC: 11740194. DOI: 10.1088/1758-5090/ad9b50.


Evaluation of mesenchymal stem cells as an model for inherited retinal diseases.

Dodina M, Gurtsieva D, Karabelsky A, Minskaia E Front Cell Dev Biol. 2024; 12:1455140.

PMID: 39620144 PMC: 11604642. DOI: 10.3389/fcell.2024.1455140.


Cancer-on-chip: a breakthrough organ-on-a-chip technology in cancer cell modeling.

Nejati B, Shahhosseini R, Hajiabbasi M, Ardabili N, Baktash K, Alivirdiloo V Med Biol Eng Comput. 2024; 63(2):321-337.

PMID: 39400856 PMC: 11750902. DOI: 10.1007/s11517-024-03199-5.


References
1.
Ghanem A, Shuler M . Combining cell culture analogue reactor designs and PBPK models to probe mechanisms of naphthalene toxicity. Biotechnol Prog. 2000; 16(3):334-45. DOI: 10.1021/bp9901522. View

2.
Gold K, Gaharwar A, Jain A . Emerging trends in multiscale modeling of vascular pathophysiology: Organ-on-a-chip and 3D printing. Biomaterials. 2018; 196:2-17. PMC: 6344330. DOI: 10.1016/j.biomaterials.2018.07.029. View

3.
McAuliffe G, Chang J, Glahn R, Shuler M . Development of a gastrointestinal tract microscale cell culture analog to predict drug transport. Mol Cell Biomech. 2008; 5(2):119-32. View

4.
Esch M, Mahler G, Stokol T, Shuler M . Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury. Lab Chip. 2014; 14(16):3081-92. PMC: 4144667. DOI: 10.1039/c4lc00371c. View

5.
Zhou J, Niklason L . Microfluidic artificial "vessels" for dynamic mechanical stimulation of mesenchymal stem cells. Integr Biol (Camb). 2012; 4(12):1487-97. PMC: 3628532. DOI: 10.1039/c2ib00171c. View